ClinicalTrials.Veeva

Menu

CardioRoot Post-Marketing Surveillance Registry

M

Maquet

Status

Completed

Conditions

Cardiovascular Surgical Procedure

Treatments

Device: CardioRoot graft

Study type

Observational

Funder types

Industry

Identifiers

NCT01609270
MCV00008317

Details and patient eligibility

About

Post-marketing surveillance registry of the CardioRoot graft.

Full description

Study objective is to monitor the performance and safety of CardioRoot vascular grafts implanted in a thoracic position. Patient survival rates will be monitored as well as immediate and long-term complications.

Enrollment

52 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients requiring a CardioRoot graft as per the CardioRoot Instructions for Use (IFU)

Exclusion criteria

  • patients with contra-indications per CardioRoot IFU
  • patients requiring consecutive aortic surgery
  • patients with coronary artery disease
  • patients who require urgent or emergent surgery

Trial design

52 participants in 1 patient group

CardioRoot
Description:
All subjects receive the CardioRoot graft at baseline implant procedure.
Treatment:
Device: CardioRoot graft

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems